<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05613049</url>
  </required_header>
  <id_info>
    <org_study_id>2022.339</org_study_id>
    <nct_id>NCT05613049</nct_id>
  </id_info>
  <brief_title>Confounding Factors of Chronic Endometritis in Women With Reproductive Failure</brief_title>
  <official_title>Confounding Factors of Chronic Endometritis in Women With Reproductive Failure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate the confounding factors of chronic endometritis and&#xD;
      therapeutic benefits of antibodies targeting plasma cells in women with reproductive failure.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Eligible women, based on the inclusion and exclusion criteria, will be recruited from the IVF&#xD;
      and/ or miscarriage clinic in the Prince of Wales Hospital/ CUHK medical centre (CUMC).&#xD;
      Endometrial sampling (ES) will alternatively be conducted during mid-luteal phase. In natural&#xD;
      cycles, all the subjects will have a daily urine test from day 9 of the menstrual cycle to&#xD;
      identify the Luteinizing Hormone (LH) surge. The ES will be obtained precisely 7 days after&#xD;
      LH surge. In artificial cycles, 6mg estradiol will be given daily orally from day 2 of the&#xD;
      menstrual cycle for 14+/-1-2 days. Transvaginal ultrasound will be performed on day 14 of the&#xD;
      estrogen therapy to assess the endometrial thickness and to exclude ovarian activity. If&#xD;
      endometrial thickness is â‰¥8 mm, plasma progesterone level is &lt; 4nmol/L, progesterone will be&#xD;
      commenced using either Endometrin (Ferring, Saint-Prex, Switzerland) 100 mg TDS vaginally. ES&#xD;
      will be obtained using a Pipelle sampler as an outpatient procedure. The ES will be obtained&#xD;
      precisely 5 days after progesterone supplementation.&#xD;
&#xD;
      Immunohistochemical staining will be used to determine plasma cells by using a mouse&#xD;
      antihuman monoclonal primary anti-CD138 antibody and anti-CD38 antibody. The total number of&#xD;
      plasma cell present in the stroma of the entire specimen will be determined and expressed as&#xD;
      plasma cell count per unit area of the specimen. If CE is present, antibiotics will be given&#xD;
      following the guideline from the Hospital Authority (HA). Then ES will be taken again to be&#xD;
      re-examined by histology and microbiology.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 26, 2023</start_date>
  <completion_date type="Anticipated">January 31, 2028</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2027</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Live birth rate</measure>
    <time_frame>31 December 2027</time_frame>
    <description>compare the brith rate between the group and cohort</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Compare the pregnancy rate between groups</measure>
    <time_frame>31 March 2028</time_frame>
    <description>compare the general pregnancy rate in women with or without CE</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the miscarriage rate between groups</measure>
    <time_frame>31 March 2028</time_frame>
    <description>compare the miscarriage rate in women with or without CE</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Compare the implantation rate between groups</measure>
    <time_frame>31 March 2028</time_frame>
    <description>Compare the implantation successful rate in women with or without CE</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">720</enrollment>
  <condition>IVF</condition>
  <arm_group>
    <arm_group_label>Observational group</arm_group_label>
    <description>Patients have 2 or more miscarriage or repeated implantation failure (RIF), or infertile women would be invited to do endometrial sampling (ES) procedure. The ES will be conducted randomly or when women undergo hysteroscopy or obtained precisely 7 days after LH surge. It will be obtained using a Pipelle sampler as an outpatient procedure.</description>
  </arm_group>
  <biospec_retention>None Retained</biospec_retention>
  <biospec_descr>
    <textblock>
      Patient will be invited to do endometrial sampling&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects will be identified and recruited from the IVF and miscarriage clinic by clinicians&#xD;
        and research nurse.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          1. Age 20-45 years;&#xD;
&#xD;
          2. Women with a history of 2 or more consecutive miscarriages before 24 weeks of&#xD;
             gestation12; or&#xD;
&#xD;
          3. Women who failed to conceive after unprotected intercourse for one year; or&#xD;
&#xD;
          4. Women who failed failure to achieve a clinical pregnancy after two consecutive cycles&#xD;
             of IVF, ICSI or frozen embryo replacement cycles where the cumulative number of&#xD;
             transferred embryos is no less than four for day-2 embryos and no less than 2 for&#xD;
             day-5 embryos (blastocysts), with all embryos being of good quality.&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          1. Uncorrected uterine anomalies, such as the septate or bicornuate uterus, fibroids&#xD;
             (submucous/intramural);&#xD;
&#xD;
          2. Untreated hydrosalpinx;&#xD;
&#xD;
          3. History of antiphospholipid syndrome;&#xD;
&#xD;
          4. Known clinical autoimmune disease;&#xD;
&#xD;
          5. Undergoing immunotherapy;&#xD;
&#xD;
          6. Abnormal thyroid function;&#xD;
&#xD;
          7. Abnormal karyotyping.&#xD;
&#xD;
          8. Those with active pelvic inflammatory disease or suspicion of infection etc.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Please kindly see the inclusion criteria. The endometrics sampling is only done for female patients.</gender_description>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacqueline Pui Wah Chung, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stacey Wong, BSc</last_name>
    <phone>35051764</phone>
    <email>staceywong@cuhk.edu.hk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>JacquelinePui Wah Chung, MBBS</last_name>
    <phone>35051764</phone>
    <email>jacquelinechung@cuhk.edu.hk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The Chinese University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>PUI WAH JACQUELINE CHUNG, MBBS</last_name>
      <phone>+852 35051537</phone>
      <email>jacquelinechung@cuhk.edu.hk</email>
    </contact>
    <contact_backup>
      <last_name>Stacey Wong, Bsc</last_name>
      <phone>+852 35051764</phone>
      <email>staceywong@cuhk.edu.hk</email>
    </contact_backup>
    <investigator>
      <last_name>PUI WAH JACQUELINE CHUNG, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>NGA PING PATRICIA IP, MBBS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>KAREN NG, MBBS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>CHI CHIU RONALD WANG, MBBS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>TAO ZHANG, MBBS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>JING XI JOSHUA LI, MBBS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>LAI PING CHEUNG, MBBS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>February 2023</verification_date>
  <study_first_submitted>November 3, 2022</study_first_submitted>
  <study_first_submitted_qc>November 10, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2022</study_first_posted>
  <last_update_submitted>February 21, 2023</last_update_submitted>
  <last_update_submitted_qc>February 21, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">February 22, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Chung Pui Wah Jacqueline</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>chronic endometritis</keyword>
  <keyword>confounding factors</keyword>
  <keyword>reproductive failure</keyword>
  <keyword>infertility</keyword>
  <keyword>IVF</keyword>
  <keyword>infertility women</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Endometritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

